Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations
- PMID: 35771775
- PMCID: PMC9246171
- DOI: 10.1371/journal.ppat.1010591
Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations
Abstract
In this review, we discuss the epidemiological dynamics of different viral infections to project how the transition from a pandemic to endemic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) might take shape. Drawing from theories of disease invasion and transmission dynamics, waning immunity in the face of viral evolution and antigenic drift, and empirical data from influenza, dengue, and seasonal coronaviruses, we discuss the putative periodicity, severity, and age dynamics of SARS-CoV-2 as it becomes endemic. We review recent studies on SARS-CoV-2 epidemiology, immunology, and evolution that are particularly useful in projecting the transition to endemicity and highlight gaps that warrant further research.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures



Similar articles
-
After the pandemic: perspectives on the future trajectory of COVID-19.Nature. 2021 Aug;596(7873):495-504. doi: 10.1038/s41586-021-03792-w. Epub 2021 Jul 8. Nature. 2021. PMID: 34237771 Review.
-
The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.Rev Med Virol. 2021 Mar;31(2):e2171. doi: 10.1002/rmv.2171. Epub 2020 Sep 18. Rev Med Virol. 2021. PMID: 33350025 Free PMC article. Review.
-
Seasonal coronavirus-specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19.J Clin Invest. 2021 Nov 1;131(21):e150613. doi: 10.1172/JCI150613. J Clin Invest. 2021. PMID: 34499051 Free PMC article.
-
Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses.Cell Rep. 2021 Dec 28;37(13):110169. doi: 10.1016/j.celrep.2021.110169. Epub 2021 Dec 7. Cell Rep. 2021. PMID: 34932974 Free PMC article.
-
The emergence of Covid-19: evolution from endemic to pandemic.J Immunoassay Immunochem. 2022 Jan 2;43(1):22-32. doi: 10.1080/15321819.2021.1991947. Epub 2021 Oct 21. J Immunoassay Immunochem. 2022. PMID: 34672900 Review.
Cited by
-
Single-Center Experience in Detecting Influenza Virus, RSV and SARS-CoV-2 at the Emergency Department.Viruses. 2023 Feb 8;15(2):470. doi: 10.3390/v15020470. Viruses. 2023. PMID: 36851685 Free PMC article.
-
Multi-center clinical evaluation of the Panther Fusion SARS-CoV-2/Flu A/B/RSV assay in nasopharyngeal swab specimens from symptomatic individuals.J Clin Microbiol. 2023 Nov 21;61(11):e0082723. doi: 10.1128/jcm.00827-23. Epub 2023 Oct 30. J Clin Microbiol. 2023. PMID: 37902331 Free PMC article.
-
Real-time monitoring of excess mortality under a new endemic regime.Euro Surveill. 2025 Jun;30(25):2400753. doi: 10.2807/1560-7917.ES.2025.30.25.2400753. Euro Surveill. 2025. PMID: 40575909 Free PMC article.
-
Persistence of SARS-CoV-2 IgG Antibody Response among South African Adults: A Prospective Cohort Study.Vaccines (Basel). 2023 Jun 6;11(6):1068. doi: 10.3390/vaccines11061068. Vaccines (Basel). 2023. PMID: 37376457 Free PMC article.
-
Age-specific transmission dynamics of SARS-CoV-2 during the first 2 years of the pandemic.PNAS Nexus. 2024 Jan 31;3(2):pgae024. doi: 10.1093/pnasnexus/pgae024. eCollection 2024 Feb. PNAS Nexus. 2024. PMID: 38312225 Free PMC article.
References
-
- Lee S, Kim T, Lee E, Lee C, Kim H, Rhee H, et al.. Clinical Course and Molecular Viral Shedding among Asymptomatic and Symptomatic Patients with SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea. JAMA Intern Med. 2020;180. doi: 10.1001/jamainternmed.2020.3862 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous